(Q37284534)

English

A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease

scientific article published on 20 May 2009

Statements

A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease (English)
20 May 2009
1192-1199

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit